Darmultraschall und progressive transmurale Remission unter Anti-IL-12/23-Antikörper

被引：0
|
作者：
Eduard F. Stange
机构：
[1] Universitätsklinikum Tübingen,Klinik für Innere Medizin I
来源：
Gastro-News | 2023年 / 10卷 / 4期
关键词：
D O I：
10.1007/s15036-023-3290-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：24 / 25
页数：1
相关论文
共 50 条
  • [31] Development in the Cynomolgus Macaque Following Administration of Ustekinumab, a Human Anti-IL-12/23p40 Monoclonal Antibody, During Pregnancy and Lactation
    Martin, Pauline L.
    Sachs, Clifford
    Imai, Noritaka
    Tsusaki, Hideshi
    Oneda, Satoru
    Jiao, Qun
    Treacy, George
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2010, 89 (05) : 351 - 363
  • [32] Pharmacologic Evaluation of Sulfasalazine, FTY720, and Anti-IL-12/23p40 in a TNBS-Induced Crohn’s Disease Model
    Zaher A. Radi
    Deborah M. Heuvelman
    Jaime L. Masferrer
    Ericka L. Benson
    Digestive Diseases and Sciences, 2011, 56 : 2283 - 2291
  • [33] Pharmacologic Evaluation of Sulfasalazine, FTY720, and Anti-IL-12/23p40 in a TNBS-Induced Crohn's Disease Model
    Radi, Zaher A.
    Heuvelman, Deborah M.
    Masferrer, Jaime L.
    Benson, Ericka L.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2283 - 2291
  • [34] Anti-IL-12/23 p40 Antibody Attenuates Chronic Graft Versus Host Disease Via Suppression of IFN-γ/IL-17-Producing Cells
    Kuroi, Taiga
    Okamoto, Sachiyo
    Saeki, Kyosuke
    Kobayashi, Yujin
    Nishimori, Hisakazu
    Fujiwara, Hideaki
    Matsuoka, Ken-ichi
    Fujii, Nobuharu
    Kondo, Eisei
    Tanimoto, Mitsune
    Maeda, Yoshinobu
    BLOOD, 2014, 124 (21)
  • [35] Efficacy of Anti-TNF-a vs Anti-IL-12/23p40 in Patients With Biological Naive Crohn's Disease: A Systemic Review and Meta-Analysis
    Al Hayek, Mohammad
    Aghneewah, Omar
    Sawaf, Bisher
    Ekreer, Moad
    Nounou, Mohamedhen Vall
    Fahaid, Ammar
    Mohamed, Mohamed
    Sardahi, Ahmed
    Abeedah, Raja
    Abduljawad, Fatimah Alzahra
    Bakeer, Hibah Bileid
    Elhadi, Muhammed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S885 - S885
  • [36] Long-term continuous maintenance therapy with CNTO 1275 (anti-IL-12/23p40) as treatment for psoriasis: Phase 3 trial results
    Gordon, Kenneth B.
    Yeilding, Newman
    Li, Shu
    Leonardi, Craig
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB4 - AB4
  • [37] LONG-TERM EXPERIENCE OF USING ANTI-IL-12/23 P40 IGG AS A REFERENCE THERAPEUTIC IN ADOPTIVE T CELL TRANSFER MODELS OF COLITIS
    Howard, Wendy
    Brown, Matthew
    Horwell, Amy
    Bonavita, Aude-Marine
    Wilson, James W.
    GASTROENTEROLOGY, 2023, 164 (06) : S421 - S422
  • [38] TUMOR NECROSIS FACTOR ANTAGONISTS ARE SUPERIOR TO ANTI-INTEGRIN AND ANTI-IL-12/23 THERAPIES FOR PREVENTING POSTOPERATIVE RECURRENCE IN ADULT CROHN'S DISEASE PATIENTS REQUIRING POSTOPERATIVE THERAPY
    Nakamura, Takahiro I.
    Shah, Ravi S.
    Chauhan, Kirtan
    Sachs, Michael
    Chang, Shannon
    Hudesman, David
    Click, Benjamin H.
    Regueiro, Miguel D.
    Axelrad, Jordan E.
    GASTROENTEROLOGY, 2020, 158 (06) : S924 - S926
  • [39] Tumour necrosis factor antagonists are superior to anti-integrin and anti-IL-12/23 therapies for preventing postoperative recurrence in adult Crohn's disease patients requiring postoperative therapy
    Nakamura, T.
    Shah, R.
    Sachs, M.
    Chang, S.
    Hudesman, D.
    Click, B.
    Axelrad, J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S436 - S437
  • [40] Anti-IL-12/23 p40 Antibody Attenuates Experimental Chronic Graft-versus-Host Disease via Suppression of IFN-γ/IL-17-Producing Cells
    Okamoto, Sachiyo
    Fujiwara, Hideaki
    Nishimori, Hisakazu
    Matsuoka, Ken-ichi
    Fujii, Nobuharu
    Kondo, Eisei
    Tanaka, Takehiro
    Yoshimura, Akihiko
    Tanimoto, Mitsune
    Maeda, Yoshinobu
    JOURNAL OF IMMUNOLOGY, 2015, 194 (03): : 1357 - 1363
12345